98 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
a/a KitW-2J/Kit+ involves: C57BL/6J	white spotting	J:192797
Adamts20bt-2H/Adamts20bt-2H Kittm1Alf/Kit+ involves: 129S2/SvPas * C57BL/6	belted	J:133403
	white spotting	J:133403
Adamts20bt-2H/Adamts20bt-2H Kittm1Alf/Kittm1Alf involves: 129S2/SvPas * C57BL/6	belted	J:133403
	white spotting	J:133403
Amhr2tm3(cre)Bhr/Amhr2+ KitW-v/KitW-v Trp53tm1Brn/Trp53tm1Brn involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J * FVB/N	increased granulosa cell tumor incidence	J:236161
	increased ovary adenoma incidence	J:236161
	increased ovary tumor incidence	J:236161
Cdkn1btm1Ako/Cdkn1b+ KitW-v/KitW-v involves: 129S1/Sv * C57BL/6J	abnormal ovary physiology	J:236161
	increased ovary adenoma incidence	J:236161
	increased ovary tumor incidence	J:236161
	premature death	J:236161
Cdkn1btm1Ako/Cdkn1btm1Ako KitW-v/KitW-v involves: 129S1/Sv * C57BL/6J	abnormal ovary physiology	J:236161
	increased ovary adenoma incidence	J:236161
	increased ovary tumor incidence	J:236161
f/f+ KitW/Kit+ FL/1Re-KitW/J	white spotting	J:24610
f/f KitW/Kit+ FL/1Re-KitW/J	abnormal erythrocyte cell number	J:24610
	decreased body weight	J:24610
	decreased hematocrit	J:24610
	decreased mean corpuscular volume	J:24610
	white spotting	J:24610
Fbn1Tsk/Fbn1+ KitW/Kit+ involves: C57BL/6 * C57BL/10 * DBA/2 * WB/ReJ	diluted coat color	J:24076
	skin fibrosis	J:24076
	tight skin	J:24076
	variable body spotting	J:24076
Fbn1Tsk/Fbn1+ KitW/KitW-v involves: C57BL/6 * C57BL/10 * DBA/2 * WB/ReJ	abnormal hypodermis morphology	J:24076
	absent coat pigmentation	J:24076
	absent mast cells	J:24076
	anemia	J:24076
	overexpanded pulmonary alveolus	J:24076
	skin fibrosis	J:24076
	tight skin	J:24076
Flt3tm1Irl/Flt3tm1Irl KitW/KitW-v involves: 129S/SvEv * C57BL/6	abnormal blood cell morphology/development	J:27238
	abnormal common myeloid progenitor cell morphology	J:27238
	abnormal leukocyte morphology	J:27238
	abnormal myelopoiesis	J:27238
	abnormal T cell number	J:27238
	decreased B cell number	J:27238
	decreased body weight	J:27238
	decreased bone marrow cell number	J:27238
	decreased double-negative T cell number	J:27238
	decreased double-positive T cell number	J:27238
	decreased lymphocyte cell number	J:27238
	decreased pre-B cell number	J:27238
	decreased pro-B cell number	J:27238
	thymus hypoplasia	J:27238
Gt(ROSA)26Sortm1(DTA)Jpmb/Gt(ROSA)26Sor+ Kittm1(cre/ERT2)Dsa/Kit+ involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6	abnormal gastrointestinal motility	J:204737
	abnormal intestinal peristalsis	J:204737
	abnormal intestinal transit time	J:204737
	abnormal synaptic transmission	J:204737
	impaired gastric peristalsis	J:204737
Gusbmps/Gusbmps KitW-41J/KitW-41J B6(C)-KitW-41J Gusbmps/BrkJ	abnormal lysosome morphology	J:58272
	decreased hematopoietic stem cell number	J:58272
	premature death	J:58272
Il2rgtm1Cgn/Il2rgtm1Cgn Kittm1.1Bsm/Kittm1.1Bsm involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6	arrested T cell differentiation	J:90485
Il3tm1Glli/Il3tm1Glli KitW/KitW-v involves: 129S2/SvPas * C57BL/6 * WB	increased susceptibility to parasitic infection	J:80500
Kittm1(cre/ERT2)Dsa/Kit+ Prkg1tm2Naw/Prkg1tm2Naw involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6	abnormal gastrointestinal motility	J:204737
	abnormal intestinal peristalsis	J:204737
	abnormal intestinal transit time	J:204737
Kittm1.1(cre)Jmol/Kittm2.1(cre/Esr1*)Jmol Gt(ROSA)26Sortm1(CAG-lacZ,-EGFP)Glh/Gt(ROSA)26Sor+ involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * FVB	abnormal heart development	J:210584
	neonatal lethality, complete penetrance	J:210584
Kittm1.1(cre)Jmol/Kittm2.1(cre/Esr1*)Jmol Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+ involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J	abnormal heart development	J:210584
	neonatal lethality, complete penetrance	J:210584
Kittm1Rosay/Kit+ Lepob/Lepob involves: 129S7/SvEvBrd * C57BL/6J	abnormal interstitial cell of Cajal morphology	J:168676
	hyperglycemia	J:168676
	obese	J:168676
	white spotting	J:168676
KitW-19H/Kit+ B6.Cg-KitW-19H/EiJ	constricted vagina orifice	J:133405
	normal reproductive system phenotype	J:133405
KitW-19H/Kit+ involves: 101/H * C3H/HeH	postnatal growth retardation	J:7681
	postnatal lethality, incomplete penetrance	J:7681
	variable body spotting	J:7681
KitW-19H/Kit+ X/SryAKR/J involves: AKR/J * C57BL/6J	sex reversal	J:133266
	small testis	J:133266
KitW-19H/KitW-19H involves: 101/H * C3H/HeH	embryonic lethality before implantation, complete penetrance	J:7681
KitW-27H/Kit+ X/SryAKR/J involves: AKR/J * C57BL/6J * CBA/H	decreased testis weight	J:133266
KitW-36H/KitW-bd involves: 101/H * C3H/HeH * STOCK Rw Fgf5go Vps33abf	absent coat pigmentation	J:20782
KitW-42J/Kit+ X/SryAKR/J involves: AKR/J * C57BL/6J	small testis	J:36829
	true hermaphroditism	J:36829
KitW-42J/Kit+ X/SryPOS-TIR involves: C57BL/6J	sex reversal	J:36829
	true hermaphroditism	J:36829
KitW-42J/KitW-42J X/SryAKR/J involves: AKR/J * C57BL/6J	abnormal internal male genitalia morphology	J:36829
	lethality throughout fetal growth and development, incomplete penetrance	J:36829
KitW-57J/Kit+ involves: C58/J	belly spot	J:38382
KitW-57J/KitW-57J involves: C58/J	anemia	J:38382
	belly spot	J:38382
	head blaze	J:38382
KitW-bd/Kit+ involves: STOCK Rw Fgf5go Vps33abf	abnormal melanoblast morphology	J:38382
	belted	J:14074
KitW-bd/KitW-bd involves: STOCK Rw Fgf5go Vps33abf	abnormal action potential	J:45208
	abnormal coat/hair pigmentation	J:13934
	abnormal melanoblast morphology	J:38382
	decreased Cajal-Retzius cell number	J:45208
KitW-e/Kit+ X/SryAKR/J involves: AKR/J * C57BL/6J	decreased testis weight	J:133266
KitW-sh/Kit+ involves: 101/H * C3H/HeH * CBA	variable body spotting	J:24351
KitW-sh/KitW-sh B6.Cg-KitW-sh/HNihrJaeBsmGlliJ	decreased susceptibility to induced hypothermia	J:275367
	decreased susceptibility to type I hypersensitivity reaction	J:275367
KitW-sh/KitW-sh involves: 101/H * C3H/HeH	abnormal coat/hair pigmentation	J:6857
	abnormal definitive hematopoiesis	J:6857
	abnormal erythrocyte cell number	J:6857
	decreased erythrocyte cell number	J:6857
	decreased mast cell degranulation	J:157470
	decreased mast cell number	J:145444
	impaired behavioral response to xenobiotic	J:157470
	increased susceptibility to parasitic infection	J:163761
KitW-sh/KitW-sh involves: 101/H * C3H/HeH * CBA	absent coat pigmentation	J:24351
KitW-sh/KitW-sh involves: C57BL/6J	abnormal vascular permeability	J:197334
	decreased susceptibility to type I hypersensitivity reaction	J:197334
KitW-sh/KitW-sh Lyntm1Ard/Lyntm1Ard involves: 101 * 129P2/OlaHsd * C3H/HeH	abnormal circulating complement protein level	J:161523
	albuminuria	J:161523
	decreased B cell number	J:161523
	glomerulonephritis	J:161523
	increased anti-double stranded DNA antibody level	J:161523
	increased anti-nuclear antigen antibody level	J:161523
	increased basophil cell number	J:161523
	increased IgA level	J:161523
	increased IgE level	J:161523
	increased IgG2b level	J:161523
	increased IgM level	J:161523
KitW-sh/KitW-v involves: 101/H * C3H/HeH	abnormal coat/hair pigmentation	J:6857
	abnormal definitive hematopoiesis	J:6857
	abnormal erythrocyte cell number	J:6857
	absent coat pigmentation	J:6857
	decreased erythrocyte cell number	J:6857
	macrocytic anemia	J:6857
KitW-v/Kit+ Ph/Ph+ involves: C57BL	abnormal coat/hair pigmentation	J:125080
	irregular coat pigmentation	J:125080
KitW-v/Kit+ Rw/Rw+ involves: 101/H * C3H/HeH * C57BL	abnormal coat/hair pigmentation	J:125080
	head spot	J:125080
	irregular coat pigmentation	J:125080
KitW-v/Kit+ Snai2tm2Grid/Snai2+ involves: 129S1/Sv * C57BL	variable body spotting	J:80529
KitW-v/Kit+ Snai2tm2Grid/Snai2tm2Grid involves: 129S1/Sv * C57BL	variable body spotting	J:80529
KitW-v/Kit+ Rps19Mhdadsk3/Rps19+ involves: C3HeB/FeJ * C57BL/6J	belly spot	J:139244
KitW-v/Kit+ Tg(Mt1-RET)304Ina/0 involves: BALB/c * C57BL/6	decreased tumor incidence	J:88074
	decreased tumor-free survival time	J:88074
	increased melanoma incidence	J:88074
KitW-v/Kit+ X/SryAKR/J involves: AKR/J * C57BL/6J	decreased testis weight	J:133266
KitW-v/KitW-v Ly6atm1Pmf/Ly6atm1Pmf involves: 129P2/OlaHsd * C57BL/6	abnormal common myeloid progenitor cell morphology	J:81387
	anemia	J:81387
	embryonic lethality, incomplete penetrance	J:81387
KitW-v/KitW-v Tg(Mt1-RET)304Ina/0 involves: BALB/c * C57BL/6	abnormal melanogenesis	J:88074
	decreased tumor incidence	J:88074
	increased melanoma incidence	J:88074
	mosaic coat color	J:88074
	premature death	J:88074
KitW-v/KitW-v Trp53tm1Brn/Trp53tm1Brn involves: 129P2/OlaHsd * C57BL/6J * FVB/N	abnormal ovary physiology	J:236161
	increased ovary tumor incidence	J:236161
	ovary cyst	J:236161
KitW/Kit+ Tg(PGK1-KITLG*220)441Daw/0 involves: C3H/HeJ	abnormal coat/hair pigmentation	J:32600
	decreased mast cell number	J:32600
	hypopigmentation	J:32600
KitW/KitW Tg(PDGFB-EPO)321Zbz/? involves: C3H * C57BL/6	abnormal B cell differentiation	J:79128
	abnormal T cell differentiation	J:79128
	decreased B cell number	J:79128
	decreased thymocyte number	J:79128
KitWps/Kit+ Pax3Sp-1Wli/Pax3+ involves: C57BL/6J * CBA/CaJ	belly spot	J:196572
	white spotting	J:196572
Mitftm5.1Arnh/Mitftm5.1Arnh Kittm1Alf/Kit+ involves: 129S2/SvPas * 129S4/SvJae * 129S6/SvEvTac * C57BL/6N	abnormal coat/hair pigmentation	J:182722
	abnormal hair follicle melanocyte morphology	J:182722
	abnormal melanocyte morphology	J:182722
	belly spot	J:182722
Mitftm7.1Arnh/Mitftm7.1Arnh Kittm1Alf/Kit+ involves: 129S2/SvPas * 129S4/SvJae * 129S6/SvEvTac * C57BL/6N	belly spot	J:182722